CoChat

Will Africans take COVID-19 vaccination?

Open access

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

The economic and humanistic impact of COVID-19 pandemic is enormous globally. No definitive treatment exists, hence accelerated development and approval of COVID-19 vaccines, offers a unique opportunity for COVID-19 prevention and control. Vaccine hesitancy may limit the success of vaccine distribution in Africa, therefore we assessed the potentials for coronavirus vaccine hesitancy and its determinants among Africans. An online cross-sectional African-wide survey was administered in Arabic, English, and French languages. Questions on demographics, self-reported health status, vaccine literacy, knowledge and perception on vaccines, past experience, behavior, infection risk, willingness to receive and affordability of the SARS-COV-2 vaccine were asked. Data were subjected to descriptive and inferential statistics. A total of 5,416 individuals completed the survey. Approximately, 94% were residents of 34 African countries while the other Africans live in the Diaspora. Only 63% of all participants surveyed were willing to receive the COVID-19 vaccination as soon as possible and 79% were worried about its side effects. Thirty-nine percent expressed concerns of vaccine-associated infection. The odds of vaccine hesitancy was 0.28 (95% CI: 0.22, 0.30) among those who believed their risk of infection was very high, compared to those who believed otherwise. The odds of vaccine hesitancy was one-fifth (OR = 0.21, 95% CI: 0.16, 0.28) among those who believed their risk of falling sick was very high, compared to those who believed their risk of falling very sick was very low. The OR of vaccine hesitancy was 2.72 (95% CI: 2.24, 3.31) among those who have previously refused a vaccine for themselves or their child compared to counterparts with no self-reported history of vaccine hesitancy. Participants want the vaccines to be mandatory (40%), provided free of charge (78%) and distributed in homes and offices (44%). COVID-19 vaccine hesitancy is substantial among Africans based on perceived risk of coronavirus infection and past experiences.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0260575

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Percentage distribution of COVID-19 vaccine acceptability and hesitancy in Africa. A total of 5211 count data was used for this analysis. Specific number of data count per country are available in the S1 Table.
Fig 1 Percentage distribution of COVID-19 vaccine acceptability and hesitancy in Africa. A total of 5211 count data was used for this analysis. Specific number of data count per country are available in the S1 Table.CC0 · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 2

  1. World Health Organization (WHO). REPORT OF THE SAGE WORKING GROUP ON VACCINE HESITANCY. 2014.
  2. University of Oxford. Our World in Data 2021 [18 March, 2021]. https://ourworldindata.org/covid-vaccinations.

Cited by

See all 95

Metadata

Authors
Anjorin, A. A., Odetokun, I. A., Abioye, A. I., Elnadi, H., Umoren, M. V., Damaris, B. F., Eyedo, J., Umar, H. I., Nyandwi, J. B., Abdalla, M. M., Tijani, S. O., Awiagah, K. S., Idowu, G. A., Fabrice, S. N. A., Maisara, A. M. O., Razouqi, Y., Mhgoob, Z. E., Parker, S., Asowata, O. E., Adesanya, I. O., Obara, M. A., Jaumdally, S., Kitema, G. F., Okuneye, T. A., Mbanzulu, K. M., Daitoni, H., Hallie, E. F., Mosbah, R., & Fasina, F. O.
Affiliations
  • Lagos State University (NG)
  • University of Ilorin (NG)
  • Harvard University (US)
  • Université de Tours (FR)
  • Cincinnati Children's Hospital Medical Center (US)
  • Medizinische Hochschule Hannover (DE)
  • Federal University of Technology (NG)
  • Gyeongsang National University (KR)
  • Minia University Hospital (EG)
  • University of Lagos (NG)
  • International University of Africa (SD)
  • Université Sultan Moulay Slimane (MA)
  • Al-Neelain University (SD)
  • University of Cape Town (ZA)
  • Africa Health Research Institute (ZA)
  • University of St Andrews (GB)
  • General Hospital Lagos, Odan (NG)
  • University of Kinshasa (CD)
  • University of Liberia (LR)
  • Zagazig University (EG)
  • Food and Agriculture Organization of the United Nations (IT)
Corresponding author
Fasina, Folorunso O.
Venue
PLOS ONE
Published
2021-12-01
Volume
16
Issue
12
Pages
e0260575
ISSN
1932-6203 (ISSN-L)
OpenAlex
W3217193330
Cited by
94
References
35
Citations by year
2026: 4 · 2025: 8 · 2024: 9 · 2023: 47 · 2022: 26
FWCI
11.45
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • Edinburgh Napier Research Repository (Edinburgh Napier University) (publishedVersion, public-domain)
  • UpSpace Institutional Repository (University of Pretoria) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • St Andrews Research Repository (St Andrews Research Repository) (submittedVersion, cc-by)
Topics
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
Keywords
COVID-19 vaccine hesitancy, COVID-19 vaccination, vaccine willingness, vaccine side effects, perceived infection risk, vaccine literacy, vaccine affordability, mandatory vaccination, vaccine distribution, Africa
MeSH terms
COVID-19, SARS-CoV-2, COVID-19 Vaccines, Adolescent, Adult, Aged, Cross-Sectional Studies, Female, Health Status, Humans, Male, Middle Aged, Surveys and Questionnaires, Vaccination, Knowledge, Black People, Young Adult, Health Literacy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.